{"id":"W2042242996","doi":"10.1016/j.coph.2005.04.001","title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","year":2005,"lang":"en","type":"review","venue":"Current Opinion in Pharmacology","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":99,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Phosphodiesterase; Roflumilast; Medicine; Phosphodiesterase 3; Adverse effect; Asthma; Pulmonary disease; Clinical trial; Pharmacology; Limiting; Intensive care medicine; Bioinformatics; Internal medicine; Enzyme; Chemistry; Biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008563367,0.001247864,0.002270265,0.0006778305,0.0002759784,0.0007906767,0.001313997,0.00154097,0.00403867],"category_scores_gemma":[0.0005556613,0.0002001468,0.0005839719,0.000630129,0.0005197748,0.001138609,0.0004301032,0.002641389,0.002662734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004935029,"about_ca_system_score_gemma":0.0004448237,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004702317,"about_ca_topic_score_gemma":0.00136953,"domain_scores_codex":[0.9998332,0.00002857527,0.00001807056,0.00003239667,0.0000594073,0.00002828287],"domain_scores_gemma":[0.9998174,0.00008775037,0.00002770668,0.000007014051,0.00003335801,0.00002682091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004301175,0.0001528876,0.0001428551,0.004899611,0.0001130434,0.0004794152,0.00003128313,0.0004019219,0.004934407,0.002910336,0.04252289,0.9429813],"study_design_scores_gemma":[0.000320051,0.0006247457,0.001209729,0.0009522457,0.0002175939,0.002779778,0.00004639439,0.0002624196,0.00293509,0.002408338,0.9882088,0.00003480566],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008560098,0.9924365,0.001134414,0.001398184,0.00127048,0.00001641321,0.00003921949,0.00004874762,0.002800073],"genre_scores_gemma":[0.004819995,0.9859453,0.0011864,0.001782474,0.001233467,0.00003299748,0.000116236,0.00001095761,0.004872126],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00403867,"threshold_uncertainty_score":0.01351064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04772506309881403,"score_gpt":0.3705159320219377,"score_spread":0.3227908689231237,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}